Change over period: —
NSE · NACLIND
NACLIND
-52.0% from the 52-week high · +5.5% above the low
NACL Industries Ltd. engages in the production of pesticides and insecticides. The company is headquartered in Hyderabad, Telangana and currently employs 1,353 full-time employees. The company went IPO on 2017-04-07. The firm is in the business of crop protection and manufactures both technical (active ingredient) and formulations. The company manufactures products in categories, such as pesticides, insecticides, acaricides, herbicides, fungicides and other plant growth chemicals. The company manufactures a range of technical, such as myclobutanil, propiconazole, profenofos, pretilachlor and tricyclazole. Its formulation business is mainly in the Indian market and sells through its retail dealer network across India. The company has a range of branded formulations. The company also exports technical and formulations and does toll manufacture for various companies. The company exports its products to over 30 nations across four continents. The firm's wholly owned subsidiaries include LR Research Laboratories Private Limited, Nagarjuna Agrichem (Australia) Pty Limited, NACL Spec-Chem Limited and NACL Multi-Chem Private Limited.
The short version. NACLIND reported revenue of ₹374 crore for Sep 2026, down 18.2% from a year earlier. Net profit was ₹-1 crore (down 133.3% year on year). Return on equity was 0.7% in Mar 2026. Promoter holding was 53.69% in Sep 2026, down 9.96 points over 8 quarters.
1 · The price
How has the stock traded?
NACLIND trades 52.0% below its 52-week high and 5.5% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹374 cr.
Sep 2026 net profit of ₹-1 cr.
1.0 pts lower than a year earlier.
Revenue compounded at -9.3% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 374 | 383 | 361 | 318 | 457 | 448 | 201 | 268 |
| Net profit | -1 | 21 | -1 | -10 | 3 | 13 | -50 | -36 |
| Net margin % | -0.4 | 5.4 | -0.2 | -3.2 | 0.6 | 2.9 | -24.8 | -13.5 |
| EPS (₹) | -0.06 | 0.89 | -0.04 | -0.43 | 0.11 | 0.56 | -2.14 | -1.56 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1584 | 1235 | 1779 | 2116 | 1640 | 1191 | 1015 | 865 |
| Net profit | 5 | -92 | -59 | 95 | 71 | 51 | 17 | -7 |
| Net margin % | 0.3 | -7.5 | -3.3 | 4.5 | 4.3 | 4.3 | 1.6 | -0.8 |
| EPS (₹) | 0.2 | -3.94 | -2.55 | 4.11 | 3.07 | 2.24 | 0.75 | -0.38 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 0.7% in Mar 2026; debt to equity is 0.44.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 0.7 | -21.6 | -11.5 | 16.5 |
| Return on capital % | 7.8 | -10.2 | -0.2 | 21.8 |
| EBITDA margin % | 5.6 | -2.1 | 1.4 | 9.5 |
| Net margin % | 0.3 | -7.4 | -3.3 | 4.5 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | -9.3% | 5.7% |
| Profit CAGR | -63.6% | -38.3% |
4 · The owners
Who holds it, and are they adding?
Down 9.96 pts over 8 quarters.
Up 0.07 pts over 8 quarters.
Up 0.83 pts over 8 quarters.
-1 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 63.65 | 63.08 | 63.07 | 53.09 | 45.69 | 53.7 | 53.69 | 53.69 | -9.96 |
| FII | 0.17 | 0.12 | 0.03 | 0.17 | 0.01 | 0.05 | 0.09 | 0.24 | +0.07 |
| DII | 0 | 0 | 1.74 | 1.32 | 1.23 | 1.46 | 1.32 | 0.83 | +0.83 |
| Public | 36.18 | 36.8 | 35.15 | 45.43 | 53.06 | 44.79 | 44.9 | 45.24 | +9.06 |
Mutual fund holdings · Oct 2026
0 schemes hold this stock
1 the month before.
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for NACLIND are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Fertilizers & Agrochemicals stocks
Quick answers
Common questions about NACLIND
What is the NACLIND share price?
NACLIND (NACLIND) last closed at ₹117.41, up 0.67% on the day. Its 52-week range is ₹110.53 to ₹243.02.
What is the market cap of NACLIND?
NACLIND has a market capitalisation of about ₹2,728 crore.
How are NACLIND's latest results?
NACLIND reported revenue of ₹374 crore for Sep 2026, down 18.2% from a year earlier. Net profit was ₹-1 crore (down 133.3% year on year). Return on equity was 0.7% in Mar 2026. Promoter holding was 53.69% in Sep 2026, down 9.96 points over 8 quarters.
Who owns NACLIND?
As of Sep 2026, shareholding was: Promoter 53.69%, FII 0.24%, DII 0.83%, Public 45.24%.
How many mutual funds hold NACLIND?
0 mutual fund schemes held NACLIND in October 2026. That compares with 1 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 12 Dec 2025 · Rights issue 5:31
- 08 Sep 2023 · Final Dividend - Rs. 0.25
- 10 Feb 2023 · Interim Dividend - Rs. 0.15
- 01 Nov 2022 · Interim Dividend - Rs. 0.3
- 15 Sep 2022 · Final Dividend - Rs. 0.15
- 10 Feb 2022 · Interim Dividend - Rs. 0.15
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.